DAVID G FAGAN

Allopathic & Osteopathic Physicians|Family Medicine VALLEY, AL NPI 1912929068

General Payments — all program years on this page

$2,589.63

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 173
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $361.07 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $361.0721

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $515.4939
2019 $589.9844
2020 $111.077
2021 $177.3811
2022 $352.5222
2023 $482.1229
2024 $361.0721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097271887 Novo Nordisk Inc $14.01 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101252084 E.R. Squibb & Sons, L.L.C. $15.51 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705335 ABBVIE INC. $22.44 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705337 ABBVIE INC. $15.09 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103705339 ABBVIE INC. $14.74 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104199567 AstraZeneca Pharmaceuticals LP $18.28 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105585942 AstraZeneca Pharmaceuticals LP $19.11 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105596357 AstraZeneca Pharmaceuticals LP $18.86 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105761008 AstraZeneca Pharmaceuticals LP $27.43 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114652186 Exact Sciences Corporation $14.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116437477 GlaxoSmithKline, LLC. $13.17 09/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116596249 GlaxoSmithKline, LLC. $14.14 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118233716 Boehringer Ingelheim Pharmaceuticals, Inc. $13.45 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118233718 Boehringer Ingelheim Pharmaceuticals, Inc. $13.83 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118890620 Otsuka America Pharmaceutical, Inc. $23.60 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136123416 Lilly USA, LLC $15.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136131708 Lilly USA, LLC $16.61 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136143429 Lilly USA, LLC $15.00 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136152339 Lilly USA, LLC $14.45 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143223085 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.06 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153294877 Dexcom, Inc. $17.29 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.